Compositions comprising platelet-derived extracellular vesicles
By combining platelet-derived extracellular vesicles with immunosuppressive and anti-inflammatory drugs, the problems of poor treatment efficacy and severe side effects in existing technologies have been solved, achieving highly effective treatment for immune and inflammatory diseases while reducing unwanted side effects and resource requirements.
Patent Information
- Application Number
- CN202480082413.0
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Priority Date
- 2023-12-28
- Filing Date
- 2024-12-19
- Publication Date
- 2026-07-24
AI Technical Summary
Existing technologies have problems with poor treatment efficacy or severe side effects in the treatment of immune and inflammatory diseases, especially for patients who do not respond well to existing drug regimens, and the resource requirements for preparing therapeutic compositions are high.
The combination of extracellular vesicles containing platelets with immunosuppressive and/or anti-inflammatory drugs is used to prevent and treat immune and inflammatory diseases, including graft-versus-host disease, transplant rejection, autoimmune diseases, and neuroinflammatory-related diseases.
It provides highly effective immunosuppression and anti-inflammatory effects, reduces unwanted side effects, and improves treatment efficacy and resource utilization efficiency.